Loading viewer...
report
Format: PDF report
This report presents a Phase 2 study evaluating nab-sirolimus and letrozole for advanced endometrioid endometrial cancer, highlighting safety and efficacy.
37 Pages
report
Fundstrat
report
Novus Holdings
report
Fabrinet
report
S&P Global